Granules' arm completes audit with USFDA

Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company completed its first audit from December 4-8, 2017 by the USFDA with one observation," the company said.

Source: The Economic Times Healthcare and Biotech News - December 11, 2017 Category: Pharmaceuticals Source Type: news